Topic: Spherix Inc.

Readies IND Filing. Spherix Incorporated (NASDAQ: SPEX) - an innovator in biotechnology for therapy in diabetes, metabolic syndrome and...
Spherix Incorporated (SPEX) leverages its scientific and technical expertise and experience through its two subsidiaries - Biospherics and Spherix...
Posted on 10/26/11 at 8:36am by Matthew Kennedy . Spherix Incorporated (NASDAQ: SPEX ) - today announced that it has entered into definitive...
Finding stocks trading below a net cash value is very rare, and here are two examples of this. Both of these companies have little revenues and are...
Shares of Spherix Incorporated (SPEX) hit a new 52-week low on Wednesday. The stock traded as low as $2.42 during mid-day trading and last traded...
Posted on 06/02/11 at 3:44pm by Benzinga Staff . Spherix Incorporated (NASDAQ: SPEXD) today announced that its drug candidate, SPX-106, achieved...
The following stocks are gapping down today (Thursday, June 2nd) during trading:. . . Shares of Sonic Foundry Inc (SOFO) are trading down 4% today...
Posted on 05/06/11 at 1:53pm by Theo Kratz . Spherix Incorporated (NASDAQ: SPEX ), an innovator in biotechnology for therapy in diabetes, metabolic...
Equities research analysts at Zacks Investment Research downgraded shares of Spherix Incorporated (NASDAQ: SPEX) from an "outperform" rating to a...
John Amatruda, M.D., a drug-development executive who was formerly Senior Vice President and Franchise Head, Diabetes and Obesity, at Merck Research Laboratories and is now an advisor to Spherix, summarized clinical trial expectations. This occurred in a subpopulation of patients using ...